MedPath

桂林南药股份有限公司

Ownership
-
Established
2001-06-22
Employees
-
Market Cap
-
Website
www.guilinpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

275

NMPA:275

Drug Approvals

Azilsartan Medoxomil Potassium Tablets

Product Name
美阿沙坦钾片
Approval Number
国药准字H20253641
Approval Date
Mar 18, 2025
NMPA

Azilsartan Medoxomil Potassium Tablets

Product Name
美阿沙坦钾片
Approval Number
国药准字H20253642
Approval Date
Mar 18, 2025
NMPA

Mebendazole

Product Name
甲苯咪唑
Approval Number
国药准字H45020015
Approval Date
Oct 9, 2024
NMPA

Albendazol

Product Name
阿苯达唑
Approval Number
国药准字H45020216
Approval Date
Oct 9, 2024
NMPA

Norfloxacin

Product Name
诺氟沙星
Approval Number
国药准字H45020299
Approval Date
Oct 9, 2024
NMPA

Guamecycline Hydrochloride

Product Name
盐酸胍甲环素
Approval Number
国药准字H45021150
Approval Date
Oct 9, 2024
NMPA

Pyrimethamine

Product Name
乙胺嘧啶
Approval Number
国药准字H20073986
Approval Date
Oct 9, 2024
NMPA

Lactasin

Product Name
乳酶生
Approval Number
国药准字H45020220
Approval Date
Oct 9, 2024
NMPA

Amodiaquine Hydrochloride

Product Name
盐酸阿莫地喹
Approval Number
国药准字H20052099
Approval Date
Oct 9, 2024
NMPA

Bumetanide

Product Name
布美他尼
Approval Number
国药准字H45020218
Approval Date
Oct 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 28
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.